

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.53716948 |
| 2 | vocalization behavior (GO:0071625) | 5.25726310 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.18762966 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.05997475 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.94295288 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.94211025 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.91419194 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.90750163 |
| 9 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.80191883 |
| 10 | glutamate secretion (GO:0014047) | 4.74001293 |
| 11 | behavioral response to nicotine (GO:0035095) | 4.73677338 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.64223704 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.63882484 |
| 14 | protein localization to synapse (GO:0035418) | 4.60063394 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.50114676 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.29363897 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.22630306 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.18391907 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.17916927 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.13340619 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.09618550 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.05801014 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.03063525 |
| 24 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.02917474 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.98935832 |
| 26 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.95115897 |
| 27 | presynaptic membrane assembly (GO:0097105) | 3.91296236 |
| 28 | exploration behavior (GO:0035640) | 3.84140173 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.83954598 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.80831982 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.77662164 |
| 32 | cerebellar granule cell differentiation (GO:0021707) | 3.74632366 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.72989315 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71040547 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.70974792 |
| 36 | behavioral response to ethanol (GO:0048149) | 3.68791179 |
| 37 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.67132446 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.65614725 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.64696335 |
| 40 | neuron recognition (GO:0008038) | 3.63407740 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.63346754 |
| 42 | postsynaptic membrane organization (GO:0001941) | 3.58428313 |
| 43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.54916568 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.54478979 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.52746812 |
| 46 | axonal fasciculation (GO:0007413) | 3.52482584 |
| 47 | long-term memory (GO:0007616) | 3.50972457 |
| 48 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.49531550 |
| 49 | neuronal action potential (GO:0019228) | 3.49358099 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.49191220 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 3.48207687 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47854039 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.46885150 |
| 54 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.44760950 |
| 55 | serotonin metabolic process (GO:0042428) | 3.44750483 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.43939563 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.42277563 |
| 58 | long-term synaptic potentiation (GO:0060291) | 3.38525379 |
| 59 | dendrite morphogenesis (GO:0048813) | 3.35811426 |
| 60 | proline transport (GO:0015824) | 3.32687700 |
| 61 | neurotransmitter transport (GO:0006836) | 3.29567557 |
| 62 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.29275060 |
| 63 | detection of light stimulus involved in visual perception (GO:0050908) | 3.29275060 |
| 64 | response to histamine (GO:0034776) | 3.27185025 |
| 65 | innervation (GO:0060384) | 3.24644916 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.23459753 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 3.23394780 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.23344855 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.22096039 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.22096039 |
| 71 | tryptophan catabolic process (GO:0006569) | 3.22096039 |
| 72 | auditory behavior (GO:0031223) | 3.21650728 |
| 73 | kynurenine metabolic process (GO:0070189) | 3.21195418 |
| 74 | primary amino compound metabolic process (GO:1901160) | 3.20712389 |
| 75 | synaptic vesicle endocytosis (GO:0048488) | 3.19875632 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 3.19465812 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16582893 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.15778618 |
| 79 | membrane depolarization during action potential (GO:0086010) | 3.12081292 |
| 80 | response to auditory stimulus (GO:0010996) | 3.10785154 |
| 81 | retinal ganglion cell axon guidance (GO:0031290) | 3.10623436 |
| 82 | synapse assembly (GO:0007416) | 3.08176870 |
| 83 | reflex (GO:0060004) | 3.07566613 |
| 84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06772438 |
| 85 | cell migration in hindbrain (GO:0021535) | 3.06726484 |
| 86 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06643295 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05559441 |
| 88 | nucleobase catabolic process (GO:0046113) | 3.05272414 |
| 89 | behavioral fear response (GO:0001662) | 3.04437879 |
| 90 | behavioral defense response (GO:0002209) | 3.04437879 |
| 91 | adult walking behavior (GO:0007628) | 3.04367951 |
| 92 | indole-containing compound metabolic process (GO:0042430) | 3.03743291 |
| 93 | response to pheromone (GO:0019236) | 3.03426430 |
| 94 | regulation of neurotransmitter levels (GO:0001505) | 3.03093637 |
| 95 | regulation of neurotransmitter transport (GO:0051588) | 3.03024300 |
| 96 | membrane depolarization (GO:0051899) | 3.02435056 |
| 97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.01958224 |
| 98 | cellular ketone body metabolic process (GO:0046950) | 3.01377332 |
| 99 | regulation of synapse maturation (GO:0090128) | 3.00173827 |
| 100 | regulation of vesicle fusion (GO:0031338) | 2.99663713 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97446828 |
| 102 | establishment of nucleus localization (GO:0040023) | 2.96524223 |
| 103 | startle response (GO:0001964) | 2.94684886 |
| 104 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.93233445 |
| 105 | regulation of action potential (GO:0098900) | 2.92997136 |
| 106 | nonmotile primary cilium assembly (GO:0035058) | 2.92621999 |
| 107 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.92158520 |
| 108 | mechanosensory behavior (GO:0007638) | 2.91960742 |
| 109 | learning (GO:0007612) | 2.91853771 |
| 110 | protein localization to cilium (GO:0061512) | 2.91642221 |
| 111 | behavioral response to cocaine (GO:0048148) | 2.91508613 |
| 112 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.90926047 |
| 113 | L-fucose catabolic process (GO:0042355) | 2.90401951 |
| 114 | fucose catabolic process (GO:0019317) | 2.90401951 |
| 115 | L-fucose metabolic process (GO:0042354) | 2.90401951 |
| 116 | striatum development (GO:0021756) | 2.88751979 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.88371811 |
| 118 | prepulse inhibition (GO:0060134) | 2.87721093 |
| 119 | central nervous system neuron axonogenesis (GO:0021955) | 2.87276397 |
| 120 | positive regulation of synapse assembly (GO:0051965) | 2.86664178 |
| 121 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.86480709 |
| 122 | positive regulation of synaptic transmission (GO:0050806) | 2.85659541 |
| 123 | neural tube formation (GO:0001841) | 2.85066798 |
| 124 | fear response (GO:0042596) | 2.84681095 |
| 125 | synaptic transmission (GO:0007268) | 2.84208641 |
| 126 | activation of protein kinase A activity (GO:0034199) | 2.82964315 |
| 127 | tryptophan metabolic process (GO:0006568) | 2.82934946 |
| 128 | synapse organization (GO:0050808) | 2.80780733 |
| 129 | vesicle transport along microtubule (GO:0047496) | 2.80679501 |
| 130 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.80440184 |
| 131 | neuromuscular process controlling balance (GO:0050885) | 2.80195037 |
| 132 | negative regulation of neurotransmitter transport (GO:0051589) | 2.79686612 |
| 133 | inner ear receptor stereocilium organization (GO:0060122) | 2.75076720 |
| 134 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.72557478 |
| 135 | epithelial cilium movement (GO:0003351) | 2.71611811 |
| 136 | ketone body metabolic process (GO:1902224) | 2.70459800 |
| 137 | retinal cone cell development (GO:0046549) | 2.70106925 |
| 138 | regulation of sarcomere organization (GO:0060297) | 2.63212466 |
| 139 | positive regulation of action potential (GO:0045760) | 2.61938176 |
| 140 | C4-dicarboxylate transport (GO:0015740) | 2.61828257 |
| 141 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.61014175 |
| 142 | spinal cord motor neuron differentiation (GO:0021522) | 2.58442849 |
| 143 | neuromuscular synaptic transmission (GO:0007274) | 2.54745186 |
| 144 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.54331329 |
| 145 | synaptic transmission, cholinergic (GO:0007271) | 2.54219209 |
| 146 | hindbrain development (GO:0030902) | 2.53168077 |
| 147 | cilium organization (GO:0044782) | 2.51409285 |
| 148 | cilium assembly (GO:0042384) | 2.50914903 |
| 149 | tachykinin receptor signaling pathway (GO:0007217) | 2.49537618 |
| 150 | action potential (GO:0001508) | 2.49268826 |
| 151 | cilium movement (GO:0003341) | 2.49251452 |
| 152 | limb bud formation (GO:0060174) | 2.48985200 |
| 153 | righting reflex (GO:0060013) | 2.48891133 |
| 154 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.48288948 |
| 155 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.48288948 |
| 156 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.48288948 |
| 157 | regulation of neurotransmitter uptake (GO:0051580) | 2.47672219 |
| 158 | photoreceptor cell maintenance (GO:0045494) | 2.44342315 |
| 159 | limb development (GO:0060173) | 2.44311827 |
| 160 | appendage development (GO:0048736) | 2.44311827 |
| 161 | adult behavior (GO:0030534) | 2.43278389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.88708282 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.99225658 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78710842 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76663207 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73330465 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39709018 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39709018 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39003991 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36145651 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.34423448 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31280975 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26691224 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21929154 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21799767 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19345050 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17912583 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13134852 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.11985362 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10536731 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09823605 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06461003 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05656953 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03540065 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02030076 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01184645 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.94908476 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94821596 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94164878 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93457370 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.92838403 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88830419 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84123546 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83305695 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81773042 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75848463 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75123932 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73617079 |
| 38 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.68732410 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68329337 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65722586 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60849412 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59997998 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57375869 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50724316 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47739609 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47376770 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45838969 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45709986 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44534451 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44534451 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44450750 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44309656 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43611602 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41215747 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36141508 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35945612 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35928846 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34913933 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34044779 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33926399 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33193524 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33052497 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32421283 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32287581 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31984221 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30556866 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29861020 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27425932 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25414121 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.24784658 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23857262 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23820518 |
| 73 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22295988 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21939460 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21818650 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21178829 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21107430 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19645811 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19523489 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19030608 |
| 81 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17786393 |
| 82 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17050304 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16671746 |
| 84 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16547184 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16236159 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15128099 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14306001 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13638513 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12006050 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12000792 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11935546 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11141066 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10822462 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10822462 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10569316 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10569316 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10554053 |
| 98 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10409579 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10298152 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10133942 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09675262 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09184292 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08573293 |
| 104 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08075324 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07852773 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07513874 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07222877 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06132542 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06010292 |
| 110 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05440791 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05398132 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05137168 |
| 113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.05054293 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04019906 |
| 115 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03358622 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02803245 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01593397 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00737592 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98510836 |
| 120 | JUN_21703547_ChIP-Seq_K562_Human | 0.97194052 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96563259 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95593522 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94945222 |
| 124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93770589 |
| 125 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92835326 |
| 126 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91734248 |
| 127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91181552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.65851441 |
| 2 | MP0003880_abnormal_central_pattern | 4.97485250 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.81112508 |
| 4 | MP0004270_analgesia | 3.69195634 |
| 5 | MP0009046_muscle_twitch | 3.25302683 |
| 6 | MP0009745_abnormal_behavioral_response | 3.21455964 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.10121551 |
| 8 | MP0002064_seizures | 3.01091152 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.95307673 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.71175942 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.69237941 |
| 12 | MP0002272_abnormal_nervous_system | 2.62647144 |
| 13 | MP0001486_abnormal_startle_reflex | 2.62589942 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.56530145 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.45434927 |
| 16 | MP0002822_catalepsy | 2.41351201 |
| 17 | MP0003787_abnormal_imprinting | 2.40339422 |
| 18 | MP0002736_abnormal_nociception_after | 2.37321010 |
| 19 | MP0000778_abnormal_nervous_system | 2.19277015 |
| 20 | MP0001984_abnormal_olfaction | 2.16452535 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.13424729 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.99767793 |
| 23 | MP0001529_abnormal_vocalization | 1.94626149 |
| 24 | MP0008569_lethality_at_weaning | 1.90823102 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.89641668 |
| 26 | MP0001970_abnormal_pain_threshold | 1.87838555 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.87346204 |
| 28 | MP0003195_calcinosis | 1.86539860 |
| 29 | MP0002184_abnormal_innervation | 1.85815453 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.83541686 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.82313720 |
| 32 | MP0004924_abnormal_behavior | 1.81255883 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.81255883 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.76515230 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.74911553 |
| 36 | MP0004858_abnormal_nervous_system | 1.64993596 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.63328430 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.60816614 |
| 39 | MP0003890_abnormal_embryonic-extraembry | 1.60562421 |
| 40 | MP0000955_abnormal_spinal_cord | 1.54955613 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.54656455 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.54601373 |
| 43 | MP0003136_yellow_coat_color | 1.51382233 |
| 44 | MP0001188_hyperpigmentation | 1.51225694 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.45210394 |
| 46 | MP0004133_heterotaxia | 1.44328796 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.40675670 |
| 48 | MP0003879_abnormal_hair_cell | 1.38526112 |
| 49 | MP0004142_abnormal_muscle_tone | 1.38150179 |
| 50 | MP0001905_abnormal_dopamine_level | 1.37280977 |
| 51 | MP0004885_abnormal_endolymph | 1.34272704 |
| 52 | MP0002938_white_spotting | 1.29799730 |
| 53 | MP0004742_abnormal_vestibular_system | 1.27531962 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.26417440 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.24026412 |
| 56 | MP0003329_amyloid_beta_deposits | 1.23588221 |
| 57 | MP0003119_abnormal_digestive_system | 1.22263073 |
| 58 | MP0004147_increased_porphyrin_level | 1.21372672 |
| 59 | MP0003122_maternal_imprinting | 1.21301750 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.20598540 |
| 61 | MP0002152_abnormal_brain_morphology | 1.19613954 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.18626034 |
| 63 | MP0004043_abnormal_pH_regulation | 1.18374661 |
| 64 | MP0008877_abnormal_DNA_methylation | 1.16575759 |
| 65 | MP0003633_abnormal_nervous_system | 1.16547513 |
| 66 | MP0002229_neurodegeneration | 1.12170628 |
| 67 | MP0000751_myopathy | 1.08905181 |
| 68 | MP0000427_abnormal_hair_cycle | 1.07022631 |
| 69 | MP0003631_nervous_system_phenotype | 1.06347316 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.05918259 |
| 71 | MP0005499_abnormal_olfactory_system | 1.05918259 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.03668589 |
| 73 | MP0008057_abnormal_DNA_replication | 1.02486424 |
| 74 | MP0002752_abnormal_somatic_nervous | 1.00652846 |
| 75 | MP0005187_abnormal_penis_morphology | 1.00020697 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 0.99215326 |
| 77 | MP0002751_abnormal_autonomic_nervous | 0.98291314 |
| 78 | MP0000372_irregular_coat_pigmentation | 0.97177626 |
| 79 | MP0000920_abnormal_myelination | 0.95101455 |
| 80 | MP0001963_abnormal_hearing_physiology | 0.93459204 |
| 81 | MP0005253_abnormal_eye_physiology | 0.91640059 |
| 82 | MP0003634_abnormal_glial_cell | 0.89489287 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.89441113 |
| 84 | MP0000516_abnormal_urinary_system | 0.89172416 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 0.89172416 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.88918507 |
| 87 | MP0003646_muscle_fatigue | 0.88622038 |
| 88 | MP0004085_abnormal_heartbeat | 0.87643323 |
| 89 | MP0003121_genomic_imprinting | 0.87101552 |
| 90 | MP0002928_abnormal_bile_duct | 0.86741794 |
| 91 | MP0003632_abnormal_nervous_system | 0.86369289 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.85921724 |
| 93 | MP0005409_darkened_coat_color | 0.85918089 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 0.85242691 |
| 95 | MP0005171_absent_coat_pigmentation | 0.84008461 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.82671692 |
| 97 | MP0008872_abnormal_physiological_respon | 0.78899087 |
| 98 | MP0001177_atelectasis | 0.78724188 |
| 99 | MP0003698_abnormal_male_reproductive | 0.78435034 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.76734198 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.76562937 |
| 102 | MP0002160_abnormal_reproductive_system | 0.76091553 |
| 103 | MP0003690_abnormal_glial_cell | 0.76017564 |
| 104 | MP0000383_abnormal_hair_follicle | 0.75992175 |
| 105 | MP0001299_abnormal_eye_distance/ | 0.74815984 |
| 106 | MP0003861_abnormal_nervous_system | 0.74541842 |
| 107 | MP0005670_abnormal_white_adipose | 0.74469317 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.72767897 |
| 109 | MP0008789_abnormal_olfactory_epithelium | 0.71898399 |
| 110 | MP0002090_abnormal_vision | 0.70641861 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.70570007 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.69107645 |
| 113 | MP0004233_abnormal_muscle_weight | 0.68989277 |
| 114 | MP0008874_decreased_physiological_sensi | 0.68935030 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.68004052 |
| 116 | MP0000026_abnormal_inner_ear | 0.62974135 |
| 117 | MP0004484_altered_response_of | 0.61825836 |
| 118 | MP0001943_abnormal_respiration | 0.61779270 |
| 119 | MP0002102_abnormal_ear_morphology | 0.61645419 |
| 120 | MP0005195_abnormal_posterior_eye | 0.61301190 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.59831529 |
| 122 | MP0010770_preweaning_lethality | 0.57457180 |
| 123 | MP0002082_postnatal_lethality | 0.57457180 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.57416735 |
| 125 | MP0010769_abnormal_survival | 0.56767856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.31384241 |
| 2 | Myokymia (HP:0002411) | 5.51714415 |
| 3 | Focal seizures (HP:0007359) | 5.29778805 |
| 4 | Atonic seizures (HP:0010819) | 5.18272395 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.98297014 |
| 6 | Febrile seizures (HP:0002373) | 4.81632385 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.38180723 |
| 8 | Pancreatic cysts (HP:0001737) | 4.20421077 |
| 9 | Absence seizures (HP:0002121) | 4.14797894 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.81088944 |
| 11 | Broad-based gait (HP:0002136) | 3.77860745 |
| 12 | True hermaphroditism (HP:0010459) | 3.75478165 |
| 13 | Dialeptic seizures (HP:0011146) | 3.74021608 |
| 14 | Action tremor (HP:0002345) | 3.73579546 |
| 15 | Visual hallucinations (HP:0002367) | 3.70410388 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 3.66818236 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.66818236 |
| 18 | Hyperventilation (HP:0002883) | 3.60487834 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.50019518 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.46925580 |
| 21 | Nephronophthisis (HP:0000090) | 3.43486965 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.33337366 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 2.99116092 |
| 24 | Truncal ataxia (HP:0002078) | 2.97065804 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 2.96684212 |
| 26 | Gait imbalance (HP:0002141) | 2.92245742 |
| 27 | Dysmetria (HP:0001310) | 2.90297963 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 2.87091265 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86370708 |
| 30 | Genetic anticipation (HP:0003743) | 2.85126877 |
| 31 | Excessive salivation (HP:0003781) | 2.83471409 |
| 32 | Drooling (HP:0002307) | 2.83471409 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.82910101 |
| 34 | Ankle clonus (HP:0011448) | 2.81633701 |
| 35 | Cystic liver disease (HP:0006706) | 2.79601204 |
| 36 | Scanning speech (HP:0002168) | 2.77407108 |
| 37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.74858522 |
| 38 | Chronic hepatic failure (HP:0100626) | 2.73884855 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.73656955 |
| 40 | Poor eye contact (HP:0000817) | 2.67656991 |
| 41 | Type II lissencephaly (HP:0007260) | 2.67260876 |
| 42 | Insidious onset (HP:0003587) | 2.61239050 |
| 43 | Termporal pattern (HP:0011008) | 2.61239050 |
| 44 | Progressive inability to walk (HP:0002505) | 2.58724281 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.58453027 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.58414200 |
| 47 | Depression (HP:0000716) | 2.57121127 |
| 48 | Spastic gait (HP:0002064) | 2.56147072 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.54811935 |
| 50 | Limb dystonia (HP:0002451) | 2.54302546 |
| 51 | Pheochromocytoma (HP:0002666) | 2.53576453 |
| 52 | Lissencephaly (HP:0001339) | 2.51398020 |
| 53 | Mutism (HP:0002300) | 2.50250803 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.48278425 |
| 55 | Amblyopia (HP:0000646) | 2.48074893 |
| 56 | Abnormal social behavior (HP:0012433) | 2.43908581 |
| 57 | Impaired social interactions (HP:0000735) | 2.43908581 |
| 58 | Sclerocornea (HP:0000647) | 2.43257481 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39634184 |
| 60 | Urinary urgency (HP:0000012) | 2.38516496 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.38091247 |
| 62 | Torticollis (HP:0000473) | 2.37589090 |
| 63 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.37507300 |
| 64 | Absent speech (HP:0001344) | 2.37502649 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37486314 |
| 66 | Postural instability (HP:0002172) | 2.36902570 |
| 67 | Anxiety (HP:0000739) | 2.31601861 |
| 68 | Impaired smooth pursuit (HP:0007772) | 2.31313503 |
| 69 | Abnormal hair whorl (HP:0010721) | 2.30877037 |
| 70 | Polyphagia (HP:0002591) | 2.29990195 |
| 71 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.26598635 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.25153049 |
| 73 | Intestinal atresia (HP:0011100) | 2.24639041 |
| 74 | Intention tremor (HP:0002080) | 2.22606996 |
| 75 | Tubular atrophy (HP:0000092) | 2.21633154 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.21356119 |
| 77 | Dysmetric saccades (HP:0000641) | 2.20955003 |
| 78 | Retinal dysplasia (HP:0007973) | 2.20675141 |
| 79 | Thickened helices (HP:0000391) | 2.20043512 |
| 80 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19496345 |
| 81 | Absent/shortened dynein arms (HP:0200106) | 2.19496345 |
| 82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18340583 |
| 83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18340583 |
| 84 | Genital tract atresia (HP:0001827) | 2.18233096 |
| 85 | Hypothermia (HP:0002045) | 2.18014158 |
| 86 | Specific learning disability (HP:0001328) | 2.17744491 |
| 87 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17382424 |
| 88 | Keratoconus (HP:0000563) | 2.16568023 |
| 89 | Increased corneal curvature (HP:0100692) | 2.16568023 |
| 90 | Cerebellar dysplasia (HP:0007033) | 2.16429504 |
| 91 | Akinesia (HP:0002304) | 2.16164944 |
| 92 | Blue irides (HP:0000635) | 2.16047374 |
| 93 | Neuroendocrine neoplasm (HP:0100634) | 2.14630180 |
| 94 | Vaginal atresia (HP:0000148) | 2.13955971 |
| 95 | Papillary thyroid carcinoma (HP:0002895) | 2.11813103 |
| 96 | Anencephaly (HP:0002323) | 2.11008330 |
| 97 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10908815 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.10347129 |
| 99 | Stereotypic behavior (HP:0000733) | 2.08176773 |
| 100 | Abnormality of binocular vision (HP:0011514) | 2.08123028 |
| 101 | Diplopia (HP:0000651) | 2.08123028 |
| 102 | Abnormality of the labia minora (HP:0012880) | 2.06482596 |
| 103 | Polydipsia (HP:0001959) | 2.06156288 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.06156288 |
| 105 | Congenital hepatic fibrosis (HP:0002612) | 2.06081927 |
| 106 | Decreased central vision (HP:0007663) | 2.05513578 |
| 107 | Focal dystonia (HP:0004373) | 2.05110576 |
| 108 | Inability to walk (HP:0002540) | 2.03951276 |
| 109 | Fair hair (HP:0002286) | 2.00553656 |
| 110 | Abnormality of alanine metabolism (HP:0010916) | 1.99802272 |
| 111 | Hyperalaninemia (HP:0003348) | 1.99802272 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99802272 |
| 113 | Generalized myoclonic seizures (HP:0002123) | 1.99604531 |
| 114 | Hemiplegia (HP:0002301) | 1.99434629 |
| 115 | Postaxial hand polydactyly (HP:0001162) | 1.99148972 |
| 116 | Aqueductal stenosis (HP:0002410) | 1.98758552 |
| 117 | Clumsiness (HP:0002312) | 1.98150224 |
| 118 | Postaxial foot polydactyly (HP:0001830) | 1.97803661 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 1.97594941 |
| 120 | Pachygyria (HP:0001302) | 1.97145965 |
| 121 | Optic nerve hypoplasia (HP:0000609) | 1.95009505 |
| 122 | Poor coordination (HP:0002370) | 1.94845736 |
| 123 | Megalencephaly (HP:0001355) | 1.94815408 |
| 124 | Hemiparesis (HP:0001269) | 1.93894629 |
| 125 | Protruding tongue (HP:0010808) | 1.92888090 |
| 126 | Central scotoma (HP:0000603) | 1.91452975 |
| 127 | Abnormality of salivation (HP:0100755) | 1.90556245 |
| 128 | Pendular nystagmus (HP:0012043) | 1.90396050 |
| 129 | Failure to thrive in infancy (HP:0001531) | 1.90150676 |
| 130 | Male pseudohermaphroditism (HP:0000037) | 1.89865110 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.89811517 |
| 132 | Patellar aplasia (HP:0006443) | 1.88644139 |
| 133 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88093034 |
| 134 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88093034 |
| 135 | Abnormal ciliary motility (HP:0012262) | 1.87724494 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.87313978 |
| 137 | Small hand (HP:0200055) | 1.86978072 |
| 138 | Furrowed tongue (HP:0000221) | 1.86919244 |
| 139 | Narrow forehead (HP:0000341) | 1.86454589 |
| 140 | Bradykinesia (HP:0002067) | 1.85576788 |
| 141 | Neurofibrillary tangles (HP:0002185) | 1.85297747 |
| 142 | Incomplete penetrance (HP:0003829) | 1.84609027 |
| 143 | Short foot (HP:0001773) | 1.84577856 |
| 144 | Craniofacial dystonia (HP:0012179) | 1.84557598 |
| 145 | Papilledema (HP:0001085) | 1.84311104 |
| 146 | Congenital stationary night blindness (HP:0007642) | 1.81398259 |
| 147 | Abnormality of macular pigmentation (HP:0008002) | 1.81039873 |
| 148 | Agitation (HP:0000713) | 1.79166750 |
| 149 | Renal cortical cysts (HP:0000803) | 1.77967743 |
| 150 | Dyskinesia (HP:0100660) | 1.76638180 |
| 151 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.76522658 |
| 152 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76496943 |
| 153 | Exotropia (HP:0000577) | 1.76097798 |
| 154 | Preaxial hand polydactyly (HP:0001177) | 1.75944976 |
| 155 | Hyperthyroidism (HP:0000836) | 1.75751079 |
| 156 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75695165 |
| 157 | Prolonged QT interval (HP:0001657) | 1.75115557 |
| 158 | Status epilepticus (HP:0002133) | 1.74925248 |
| 159 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73587756 |
| 160 | Large for gestational age (HP:0001520) | 1.72718136 |
| 161 | Volvulus (HP:0002580) | 1.72634635 |
| 162 | Oligodactyly (hands) (HP:0001180) | 1.70600010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.94698333 |
| 2 | MARK1 | 3.66614646 |
| 3 | EPHA4 | 3.62802471 |
| 4 | NTRK3 | 3.54904125 |
| 5 | CASK | 3.52959917 |
| 6 | MAP3K4 | 3.32580387 |
| 7 | MAP3K9 | 3.26695889 |
| 8 | MAP2K7 | 3.08318622 |
| 9 | BMPR1B | 2.54732630 |
| 10 | ADRBK2 | 2.40251064 |
| 11 | MINK1 | 2.40126717 |
| 12 | NTRK2 | 2.35686345 |
| 13 | INSRR | 2.14681160 |
| 14 | PRPF4B | 2.03167239 |
| 15 | ACVR1B | 2.01387214 |
| 16 | PAK6 | 1.92861334 |
| 17 | KSR1 | 1.86729722 |
| 18 | MAPK13 | 1.82536553 |
| 19 | TNIK | 1.74717806 |
| 20 | MAP2K4 | 1.73211811 |
| 21 | DAPK2 | 1.72794468 |
| 22 | MAP4K2 | 1.66412858 |
| 23 | GRK1 | 1.61270287 |
| 24 | MKNK2 | 1.58657630 |
| 25 | SIK3 | 1.55345473 |
| 26 | KSR2 | 1.51812718 |
| 27 | SGK223 | 1.51526744 |
| 28 | SGK494 | 1.51526744 |
| 29 | SGK2 | 1.45364463 |
| 30 | PLK2 | 1.44601934 |
| 31 | CDK19 | 1.44505250 |
| 32 | ZAK | 1.37203730 |
| 33 | CDK5 | 1.37018331 |
| 34 | MAP3K12 | 1.36707600 |
| 35 | BMPR2 | 1.32452772 |
| 36 | CAMKK1 | 1.31352171 |
| 37 | NUAK1 | 1.27215264 |
| 38 | PRKD3 | 1.25195763 |
| 39 | BCR | 1.21955411 |
| 40 | AKT3 | 1.21493204 |
| 41 | OXSR1 | 1.21457716 |
| 42 | WNK4 | 1.20961568 |
| 43 | NTRK1 | 1.15476170 |
| 44 | CAMKK2 | 1.14491045 |
| 45 | PHKG2 | 1.14170495 |
| 46 | PHKG1 | 1.14170495 |
| 47 | SIK2 | 1.11487743 |
| 48 | CSNK1G2 | 1.10549721 |
| 49 | TRIM28 | 1.09943781 |
| 50 | SGK3 | 1.09264088 |
| 51 | TYRO3 | 1.05584676 |
| 52 | MAP3K6 | 1.04666425 |
| 53 | CAMK2A | 1.04027508 |
| 54 | TAF1 | 1.02545538 |
| 55 | PRKCG | 1.02157335 |
| 56 | UHMK1 | 1.00472641 |
| 57 | PNCK | 0.98256630 |
| 58 | DAPK1 | 0.98219807 |
| 59 | STK38 | 0.97336370 |
| 60 | PRKCH | 0.92013964 |
| 61 | MAP3K13 | 0.91658469 |
| 62 | GRK5 | 0.91275151 |
| 63 | ERBB3 | 0.89394177 |
| 64 | CDK18 | 0.89365840 |
| 65 | BRAF | 0.88503225 |
| 66 | FGFR2 | 0.85909263 |
| 67 | STK11 | 0.84182172 |
| 68 | TLK1 | 0.82999447 |
| 69 | STK38L | 0.82730775 |
| 70 | CDK15 | 0.80927378 |
| 71 | ARAF | 0.80593040 |
| 72 | CAMK2B | 0.80060562 |
| 73 | TAOK1 | 0.77898855 |
| 74 | CDK14 | 0.76356460 |
| 75 | PAK3 | 0.75234472 |
| 76 | RIPK4 | 0.74730301 |
| 77 | WNK1 | 0.74657999 |
| 78 | CCNB1 | 0.74530138 |
| 79 | FES | 0.71747272 |
| 80 | MKNK1 | 0.71589741 |
| 81 | STK39 | 0.71574150 |
| 82 | SGK1 | 0.70882492 |
| 83 | PKN1 | 0.69453683 |
| 84 | CDK11A | 0.66474531 |
| 85 | MARK2 | 0.65286341 |
| 86 | CAMK4 | 0.65147581 |
| 87 | LATS2 | 0.64042743 |
| 88 | RET | 0.61923448 |
| 89 | PINK1 | 0.61460761 |
| 90 | DYRK1A | 0.60885368 |
| 91 | CSNK1G3 | 0.60019929 |
| 92 | CAMK1 | 0.59996851 |
| 93 | TAOK3 | 0.59861984 |
| 94 | DYRK2 | 0.57484004 |
| 95 | CSNK1A1L | 0.57280641 |
| 96 | TGFBR1 | 0.56489216 |
| 97 | PRKCE | 0.56359352 |
| 98 | CAMK1G | 0.54668599 |
| 99 | NEK6 | 0.54648328 |
| 100 | CAMK2D | 0.51752074 |
| 101 | CDK3 | 0.51082007 |
| 102 | TIE1 | 0.50631836 |
| 103 | WNK3 | 0.50511646 |
| 104 | ROCK2 | 0.50004599 |
| 105 | MAPKAPK5 | 0.49446060 |
| 106 | MUSK | 0.48670726 |
| 107 | PRKACA | 0.47880402 |
| 108 | ERBB2 | 0.45956750 |
| 109 | PTK2B | 0.45826045 |
| 110 | EPHA3 | 0.45674112 |
| 111 | CSNK1G1 | 0.45105319 |
| 112 | RPS6KA3 | 0.44920269 |
| 113 | MOS | 0.44884596 |
| 114 | PRKAA1 | 0.44144778 |
| 115 | PIK3CA | 0.43309226 |
| 116 | ERBB4 | 0.43185416 |
| 117 | LMTK2 | 0.43075081 |
| 118 | RAF1 | 0.42708026 |
| 119 | CDC42BPA | 0.42457088 |
| 120 | MAP3K2 | 0.42302965 |
| 121 | CSNK1D | 0.41940286 |
| 122 | CAMK2G | 0.41821068 |
| 123 | CAMK1D | 0.41440754 |
| 124 | GRK7 | 0.41313358 |
| 125 | MAPK10 | 0.41164096 |
| 126 | PRKCZ | 0.40297124 |
| 127 | PLK4 | 0.40109594 |
| 128 | MAP2K6 | 0.40015036 |
| 129 | OBSCN | 0.39556269 |
| 130 | PDK1 | 0.38429736 |
| 131 | PRKACB | 0.37713151 |
| 132 | FYN | 0.36707895 |
| 133 | ADRBK1 | 0.36296930 |
| 134 | WEE1 | 0.35730788 |
| 135 | PRKG1 | 0.35539019 |
| 136 | VRK1 | 0.34340847 |
| 137 | BRSK2 | 0.33147086 |
| 138 | CSNK1A1 | 0.31835270 |
| 139 | PRKCA | 0.30070042 |
| 140 | CSNK1E | 0.29758584 |
| 141 | PRKCB | 0.28977463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.94758798 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26166722 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83241961 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80681819 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.78095014 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.72983192 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69126094 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68398911 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.56980275 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42787232 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18199350 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.15934604 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.95576973 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.90815746 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89390196 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89315032 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88763522 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.87202349 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.80711502 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.73821449 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.73024968 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67986029 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66038508 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.64527480 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64078635 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59615880 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59392456 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56053553 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55277418 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51900431 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49540909 |
| 32 | Axon guidance_Homo sapiens_hsa04360 | 1.48050210 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47647330 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46849041 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39175951 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37016639 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30303355 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.28843381 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27749957 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24412211 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.24382816 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22768556 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21405232 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.20489218 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17129346 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17004407 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16844398 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11822920 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09312946 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06585825 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.06523718 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05306176 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04561160 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04010067 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03948738 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03858622 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02794317 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01447799 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96715570 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.96609872 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96307013 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94479658 |
| 63 | Protein export_Homo sapiens_hsa03060 | 0.92727999 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92695009 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92065812 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.91312253 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.89892198 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89154815 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88546802 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87852086 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86463258 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86402596 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80808368 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80475830 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80317903 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79495080 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78247819 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76817507 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76263141 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74906797 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74708019 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72678151 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72475092 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71857658 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69227425 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65894445 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65129440 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65119744 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63123922 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62485166 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62145153 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62051902 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61807469 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61207465 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60627991 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59840973 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59499801 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57696333 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57288012 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57285302 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.56351703 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54734754 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54283345 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53747884 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53274250 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53041284 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52850989 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52801246 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52285473 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51300116 |
| 111 | RNA polymerase_Homo sapiens_hsa03020 | 0.51007200 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50693706 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50032424 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.48650901 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48017066 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47859749 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47851303 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46310167 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44520365 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.44429543 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43689429 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43035014 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42901330 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42541193 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.42039277 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41923274 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41901664 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39777334 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39642346 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39000805 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38660363 |
| 132 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38482969 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38021081 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37976221 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37770465 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37239043 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37221878 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36291386 |
| 139 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34731599 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34414773 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33708501 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33466357 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31306672 |
| 144 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27593885 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.27247790 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26716389 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.26634855 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26146215 |

